, Question 1
A patient with heart failure and reduced ejection fraction (HFrEF) is initiated
on sacubitril/valsartan. Which mechanism explains why this combination
reduces cardiovascular mortality more effectively than enalapril alone?
A. Sacubitril inhibits neprilysin, increasing natriuretic peptides, while
valsartan blocks angiotensin II receptors, providing dual cardioprotection.
B. Sacubitril enhances bradykinin degradation, and valsartan increases
angiotensin II synthesis, leading to improved vasodilation.
C. Sacubitril acts as a direct renin inhibitor, and valsartan inhibits
aldosterone synthase, reducing sodium retention.
D. Sacubitril blocks angiotensin-converting enzyme, and valsartan
stimulates AT2 receptors, promoting reverse remodeling.
Correct Answer: A - Sacubitril inhibits neprilysin, increasing
natriuretic peptides, while valsartan blocks angiotensin II
receptors, providing dual cardioprotection.
RATIONALE
Sacubitril inhibits neprilysin, raising natriuretic peptides that promote
vasodilation and diuresis, while valsartan blocks AT1 receptors,
reducing vasoconstriction and aldosterone. This dual mechanism
outperforms ACE inhibition alone. Options B, C, and D misstate the
pharmacology of sacubitril and valsartan.
Question 2
A patient with type 2 diabetes on metformin and empagliflozin develops a
urinary tract infection and is prescribed ciprofloxacin. Which interaction is
most concerning?
A. Ciprofloxacin increases empagliflozin levels, leading to
hypoglycemia.
B. Ciprofloxacin reduces metformin clearance, increasing risk of lactic
acidosis.
Page 2
, C. Empagliflozin increases ciprofloxacin nephrotoxicity, causing acute
kidney injury.
D. Metformin decreases ciprofloxacin absorption, reducing its efficacy.
Correct Answer: B - Ciprofloxacin reduces metformin clearance,
increasing risk of lactic acidosis.
RATIONALE
Ciprofloxacin inhibits OCT2 and MATE transporters, reducing renal
tubular secretion of metformin, which can elevate metformin levels
and precipitate lactic acidosis. The other interactions are not clinically
significant or are incorrectly described.
Question 3
A patient with asthma is prescribed montelukast. Which statement best reflects
its role in therapy?
A. It is a long-acting beta-agonist that provides bronchodilation for acute
symptoms.
B. It is a leukotriene receptor antagonist that reduces airway inflammation
and is used for prophylaxis, not acute attacks.
C. It is an inhaled corticosteroid that suppresses airway inflammation but
has no effect on leukotrienes.
D. It is a mast cell stabilizer that prevents histamine release but does not
affect leukotrienes.
Correct Answer: B - It is a leukotriene receptor antagonist that
reduces airway inflammation and is used for prophylaxis, not
acute attacks.
RATIONALE
Montelukast blocks cysteinyl leukotriene receptors, decreasing
inflammation and bronchoconstriction; it is indicated for chronic
asthma control, not acute exacerbations. Options A, C, and D
misidentify its drug class and mechanism.
Page 3
, Question 4
A patient with gastroesophageal reflux disease (GERD) is started on
omeprazole. Which pharmacokinetic property best explains why it should be
taken 30 minutes before a meal?
A. Food increases gastric pH, enhancing omeprazole absorption.
B. Omeprazole is a prodrug activated by acid; food stimulates proton
pump activity, improving efficacy.
C. Omeprazole is acid-labile; food delays gastric emptying, allowing
more time for absorption in the small intestine.
D. Omeprazole requires an acidic environment for activation, and food
increases gastric acid secretion, maximizing its effect on proton pumps.
Correct Answer: D - Omeprazole requires an acidic environment
for activation, and food increases gastric acid secretion,
maximizing its effect on proton pumps.
RATIONALE
Omeprazole is a prodrug that requires acid for activation into its active
form, which then irreversibly inhibits proton pumps. Taking it before a
meal ensures peak plasma concentration coincides with maximal
proton pump activity. Options A, B, and C are incorrect
pharmacokinetic explanations.
Question 5
A patient with bipolar disorder on lithium carbonate presents with coarse
tremor, ataxia, and confusion. Serum lithium level is 2.1 mEq/L. Which
intervention is priority?
A. Administer a benzodiazepine for agitation.
B. Initiate hemodialysis immediately.
C. Hold lithium and administer intravenous fluids with sodium.
D. Give activated charcoal to bind lithium.
Correct Answer: C - Hold lithium and administer intravenous
Page 4
A patient with heart failure and reduced ejection fraction (HFrEF) is initiated
on sacubitril/valsartan. Which mechanism explains why this combination
reduces cardiovascular mortality more effectively than enalapril alone?
A. Sacubitril inhibits neprilysin, increasing natriuretic peptides, while
valsartan blocks angiotensin II receptors, providing dual cardioprotection.
B. Sacubitril enhances bradykinin degradation, and valsartan increases
angiotensin II synthesis, leading to improved vasodilation.
C. Sacubitril acts as a direct renin inhibitor, and valsartan inhibits
aldosterone synthase, reducing sodium retention.
D. Sacubitril blocks angiotensin-converting enzyme, and valsartan
stimulates AT2 receptors, promoting reverse remodeling.
Correct Answer: A - Sacubitril inhibits neprilysin, increasing
natriuretic peptides, while valsartan blocks angiotensin II
receptors, providing dual cardioprotection.
RATIONALE
Sacubitril inhibits neprilysin, raising natriuretic peptides that promote
vasodilation and diuresis, while valsartan blocks AT1 receptors,
reducing vasoconstriction and aldosterone. This dual mechanism
outperforms ACE inhibition alone. Options B, C, and D misstate the
pharmacology of sacubitril and valsartan.
Question 2
A patient with type 2 diabetes on metformin and empagliflozin develops a
urinary tract infection and is prescribed ciprofloxacin. Which interaction is
most concerning?
A. Ciprofloxacin increases empagliflozin levels, leading to
hypoglycemia.
B. Ciprofloxacin reduces metformin clearance, increasing risk of lactic
acidosis.
Page 2
, C. Empagliflozin increases ciprofloxacin nephrotoxicity, causing acute
kidney injury.
D. Metformin decreases ciprofloxacin absorption, reducing its efficacy.
Correct Answer: B - Ciprofloxacin reduces metformin clearance,
increasing risk of lactic acidosis.
RATIONALE
Ciprofloxacin inhibits OCT2 and MATE transporters, reducing renal
tubular secretion of metformin, which can elevate metformin levels
and precipitate lactic acidosis. The other interactions are not clinically
significant or are incorrectly described.
Question 3
A patient with asthma is prescribed montelukast. Which statement best reflects
its role in therapy?
A. It is a long-acting beta-agonist that provides bronchodilation for acute
symptoms.
B. It is a leukotriene receptor antagonist that reduces airway inflammation
and is used for prophylaxis, not acute attacks.
C. It is an inhaled corticosteroid that suppresses airway inflammation but
has no effect on leukotrienes.
D. It is a mast cell stabilizer that prevents histamine release but does not
affect leukotrienes.
Correct Answer: B - It is a leukotriene receptor antagonist that
reduces airway inflammation and is used for prophylaxis, not
acute attacks.
RATIONALE
Montelukast blocks cysteinyl leukotriene receptors, decreasing
inflammation and bronchoconstriction; it is indicated for chronic
asthma control, not acute exacerbations. Options A, C, and D
misidentify its drug class and mechanism.
Page 3
, Question 4
A patient with gastroesophageal reflux disease (GERD) is started on
omeprazole. Which pharmacokinetic property best explains why it should be
taken 30 minutes before a meal?
A. Food increases gastric pH, enhancing omeprazole absorption.
B. Omeprazole is a prodrug activated by acid; food stimulates proton
pump activity, improving efficacy.
C. Omeprazole is acid-labile; food delays gastric emptying, allowing
more time for absorption in the small intestine.
D. Omeprazole requires an acidic environment for activation, and food
increases gastric acid secretion, maximizing its effect on proton pumps.
Correct Answer: D - Omeprazole requires an acidic environment
for activation, and food increases gastric acid secretion,
maximizing its effect on proton pumps.
RATIONALE
Omeprazole is a prodrug that requires acid for activation into its active
form, which then irreversibly inhibits proton pumps. Taking it before a
meal ensures peak plasma concentration coincides with maximal
proton pump activity. Options A, B, and C are incorrect
pharmacokinetic explanations.
Question 5
A patient with bipolar disorder on lithium carbonate presents with coarse
tremor, ataxia, and confusion. Serum lithium level is 2.1 mEq/L. Which
intervention is priority?
A. Administer a benzodiazepine for agitation.
B. Initiate hemodialysis immediately.
C. Hold lithium and administer intravenous fluids with sodium.
D. Give activated charcoal to bind lithium.
Correct Answer: C - Hold lithium and administer intravenous
Page 4
